Get started

CELG

$CELG Celgene LT Downtrend - $20M Bearish Options Bet$CELG Celgene long term chart looks to be in a clear downtrend. With a 50d/200d ema death cross on the weekly chart back in May and an inability to break through the 50d ema line in late August, (barring a significant earnings beat next week) I'm expecting this downtrend to continue into the final months of the year. Adding to the bearish sentiment, we saw some notable put buying today with $20M+ of deep in-the-money Jan'19 puts traded - about 5,100 contracts for an average price of about $4,400. On the daily chart there is a 5 year-old un-filled gap from mid-2013 around $62.50. I'm targeting this mid-60s area by Dec-Jan time frame. Note: Informational analysis, not investment advice.
CShort
by Triple_Barrel_Capital
($celg) Celgene: not so fastCelgene helped by the company's buyback has turned positive after a complicated year. Despite this in terms of foundamentals two drugs are on the way to be developped but such developments will be revealed in the next year so patient is a must for those who wants to invest of something concreate. On a technical point of view yesterday price faild to cross MA 200. This is an importante resistence and a tp for those who bought shares in the last weeks as the RSI is overbought, thus a little pullback is expected in the next days. Levels to watch are the followings as reported: 89.20, 86.27.
CLong
by TRADOMICS_
Celgene ($celg) if tomorrow...if only tomorrow....Weekly chart: we have the downtrend channel clearly defined on a weekly basis. On a monthly basis we have already had a minimum of swing with a dragon fly bullish, on a daily chart some signs of an incoming uptrend as described in the latest posts...but tomorrow...tomorrow is where we play the game with the last resistence in place at 86.72 dollars. Once we get out of the channel and we leave this solid resistance it will mean that Celgene will be ready to come back to war. I will be long in case the price breaks such thresold because signs of long will get really clear.
C
by TRADOMICS_
Celgene is under the radarCelg is under the radar because after an insane downtrend, calm and a bit of optimism is getting back. Price is consolidating in a narrow range and on friday we have seen a first endeavour to break the flag with no success. This has happend because MA 50 has acted like a resistence. If the price breaks the wall of 80/80.50 with momentum I expect a new buy long with a new uptrend. As showed price has never tried to under 74 dollars since several weeks, plus volatility is really squeezed. I will carefully watch the graph along the next weeks (watch and wait).
C
by TRADOMICS_
2
CELG - Swing Trade - countertrendRules of Engagement Price is at a 200% extension of the previous swing on the Daily chart A 1-2-3 pattern has formed on the 1hr or 4hr chart ie. A prior swing high has been taken out by price action confirming our entry. Analysis Price at Daily support and order flow is forming a fractal. Sellers are taking profit and the Bulls are looking at an entry as price is at 2014 weekly support. Price has formed a higher high and on the lower time frame chart forming a change of trend on the 1hr. This gives an opportunity to understand our risk and set our stop under the last swing low. Once the swing high at the 79.39 is taken out and a candle closes above this level we wait for a pullback then enter. Entry: 79:39 Stop: 76:10 Target #1 : 80:83 -127% extension of the first move after the final leg down & 38.2% Retracement Target # 2: 81:02 -161.8% extension.
CLong
by gillianpatrice
4
CELG Q1 2018 Earnings on 5/4 - Are Traders Rotating In or Out?What a tumultuous market. Celgene reports earnings on 5/4. Earnings play aside, are traders and investors rotating into or out of pharmaceuticals? The market doesn't know what to do with itself right now. With a Fed meeting taking place over the next couple days, Caterpillar's CFO claiming we've seen a "high water mark" with Q1 earnings, rate concerns, trade concerns, and historic geopolitical uncertainty (especially regarding Iran's nuclear program), some traders claim we've already seen April and May's strongly anticipated earnings rally. If that's true, 1. what a squishy rally, and 2. where do we go from here? Thanks in advance for lending me your attention! Pharmaceuticals are a wild card among the classical winners (usually, financials, materials, and energy) and losers (REITs, utilities, etc.) in a late-cycle rotation. It can be argued a lot of Wall Street cash has sought the arguably greener pastures of cryptocurrencies. But could we see prices move upward along the right side of the chart in pharmaceutical companies? CELG reports earnings on 5/4. Celgene took a dive on 4/30 on troubling news about a drug in its development pipeline. Did that drop make Celgene a bargain buy? CELG's drop on bad news has put it at technical support. The uncertainty of its earnings report and the market overall has it arguably priced cheap. Is Celgene a cheap buy in this market with a possible earnings surprise on 5/4 and upside potential with a rotation into pharma? Please like, follow, and share, and maybe we can have fun and do great things together. Thanks again! See it on the site: holsturr.com/category/markets/charts/ ** For speculative and research purposes only - good luck! **
CLong
by holsturr